220 participants
Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-31
- Start Date:
- 2025-07-30
- Completion:
- 2028-06-30
Conditions
- Non-Small Cell Lung Cancer
Interventions
- DRUG
No Results Yet